FLAGYL I.V. Drug Patent Profile
✉ Email this page to a colleague
When do Flagyl I.v. patents expire, and when can generic versions of Flagyl I.v. launch?
Flagyl I.v. is a drug marketed by Pfizer and Baxter Hlthcare and is included in two NDAs.
The generic ingredient in FLAGYL I.V. is metronidazole. There are eighteen drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flagyl I.v.
A generic version of FLAGYL I.V. was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLAGYL I.V.?
- What are the global sales for FLAGYL I.V.?
- What is Average Wholesale Price for FLAGYL I.V.?
Summary for FLAGYL I.V.
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 77 |
| DailyMed Link: | FLAGYL I.V. at DailyMed |
Recent Clinical Trials for FLAGYL I.V.
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical College of Wisconsin | EARLY_PHASE1 |
| Gateway Pharmaceutical LLC | PHASE1 |
| Hayder Adnan Fawzi | PHASE2 |
US Patents and Regulatory Information for FLAGYL I.V.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | FLAGYL I.V. | metronidazole hydrochloride | INJECTABLE;INJECTION | 018353-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | FLAGYL I.V. RTU IN PLASTIC CONTAINER | metronidazole | INJECTABLE;INJECTION | 018657-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pfizer | FLAGYL I.V. RTU IN PLASTIC CONTAINER | metronidazole | INJECTABLE;INJECTION | 018353-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
